版本:
中国

BRIEF-Trillium Therapeutics offers shares in public offering

May 25 Trillium Therapeutics Inc

* Trillium announces proposed public offering

* Trillium therapeutics inc - intends to use net proceeds of offering to advance and expand current phase 1 trial of sirpαfc

* Trillium therapeutics - to use net proceeds to initiate , conduct a phase 1 trial for tti-622 with dose escalation and expansion phase focused on combination treatment Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐